Enovis Corporation (ENOV) 10-Year Financial Performance & Capital Metrics

ENOV • • Industrial / General

IndustrialsIndustrial MachinerySpecialized Industrial ComponentsFiltration & Sealing Systems

AboutEnovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.Show more

Revenue $2.11B +23.5%
EBITDA -$491M -424.3%
Net Income -$825M -2381.9%
EPS (Diluted) -14.93 -2347.5%
Gross Margin 56.02% -3.5%
EBITDA Margin -23.29% -362.7%
Operating Margin -36.81% -856.3%
Net Margin -39.17% -1910.3%
ROE -27.59% -2749.1%
ROIC -14.84% -1056.4%
Debt/Equity 0.55 +249.2%
Interest Coverage -13.59 -308.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.5x book value

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Weak momentum: RS Rating 17 (bottom 17%)
✗Sales declining 8.7% over 5 years
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-7.56%

5Y-8.73%

3Y13.9%

TTM11.57%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-1047.04%

EPS CAGR

10Y-

5Y-

3Y-

TTM-528.76%

ROCE

10Y Avg-0.59%

5Y Avg-4.7%

3Y Avg-7.19%

Latest-18.63%

Peer Comparison

Filtration & Sealing Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NPOEnPro Industries, Inc.	5.09B	241.74	70.07	-1%	7.81%	5.68%	2.55%	0.49
CSWCSW Industrials, Inc.	5.49B	328.94	39.25	10.78%	14.88%	12.5%	2.77%	0.06
DCIDonaldson Company, Inc.	11.62B	100.73	33.03	2.92%	10.25%	25.18%	2.93%	0.50
GTESGates Industrial Corporation plc	5.95B	23.05	31.15	-4.54%	6.93%	6.37%	4.98%	0.74
ITTITT Inc.	15.75B	183.08	29.06	10.59%	12.67%	18.09%	2.78%	0.27
ITWIllinois Tool Works Inc.	75.97B	261.89	22.36	-1.3%	19.05%	94.27%	3.74%	2.44
ENOVEnovis Corporation	1.39B	24.26	-1.62	23.46%	-61.22%	-67.56%		0.55

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	3.97B	3.65B	3.3B	3.67B	3.33B	1.12B	1.43B	1.56B	1.71B	2.11B
Revenue Growth %	-0.14%	-0.08%	-0.1%	0.11%	-0.09%	-0.66%	0.27%	0.1%	0.09%	0.23%
Cost of Goods Sold+	2.72B	2.5B	2.27B	2.53B	1.93B	517.06M	648.51M	693.72M	716.42M	926.87M
COGS % of Revenue	0.68%	0.69%	0.69%	0.69%	0.58%	0.46%	0.45%	0.44%	0.42%	0.44%
Gross Profit+	1.25B	1.15B	1.03B	1.13B	1.4B	603.64M	777.67M	869.38M	990.78M	1.18B
Gross Margin %	0.32%	0.31%	0.31%	0.31%	0.42%	0.54%	0.55%	0.56%	0.58%	0.56%
Gross Profit Growth %	-0.15%	-0.08%	-0.1%	0.1%	0.24%	-0.57%	0.29%	0.12%	0.14%	0.19%
Operating Expenses+	905.95M	825.24M	732.34M	818.21M	1.2B	669.82M	840.47M	940.56M	1.06B	1.96B
OpEx % of Revenue	0.23%	0.23%	0.22%	0.22%	0.36%	0.6%	0.59%	0.6%	0.62%	0.93%
Selling, General & Admin	905.95M	825.24M	732.34M	818.21M	1.13B	515.47M	665.77M	772.91M	830.3M	939.36M
SG&A % of Revenue	0.23%	0.23%	0.22%	0.22%	0.34%	0.46%	0.47%	0.49%	0.49%	0.45%
Research & Development	41.5M	39.3M	42.9M	34.2M	0	34.27M	49.09M	60.83M	75.33M	91.3M
R&D % of Revenue	0.01%	0.01%	0.01%	0.01%	-	0.03%	0.03%	0.04%	0.04%	0.04%
Other Operating Expenses	-21.09M	-8.23M	-46.93M	39K	65.3M	120.09M	125.61M	106.82M	150.85M	925.81M
Operating Income+	284.64M	238.01M	29.15M	236.94M	203.61M	-66.18M	-62.8M	-71.18M	-65.71M	-775.72M
Operating Margin %	0.07%	0.07%	0.01%	0.06%	0.06%	-0.06%	-0.04%	-0.05%	-0.04%	-0.37%
Operating Income Growth %	-0.3%	-0.16%	-0.88%	7.13%	-0.14%	-1.33%	0.05%	-0.13%	0.08%	-10.81%
EBITDA+	439.19M	347.88M	152.57M	378.82M	439.64M	180.05M	200.12M	148.53M	151.4M	-490.92M
EBITDA Margin %	0.11%	0.1%	0.05%	0.1%	0.13%	0.16%	0.14%	0.1%	0.09%	-0.23%
EBITDA Growth %	-0.25%	-0.21%	-0.56%	1.48%	0.16%	-0.59%	0.11%	-0.26%	0.02%	-4.24%
D&A (Non-Cash Add-back)	154.54M	109.86M	123.42M	141.88M	236.03M	246.23M	262.92M	219.71M	217.11M	284.8M
EBIT	276.05M	239.4M	36.99M	141.45M	170M	-66.18M	-92.67M	21.98M	-47.38M	-765.82M
Net Interest Income+	-47.5M	-30.28M	-40.11M	-49.08M	-119.5M	-52.82M	-29.11M	-24.75M	-19.75M	-57.1M
Interest Income	0	0	0	0	0	0	0	200K	0	0
Interest Expense	47.74M	30.02M	40.11M	49.08M	119.5M	52.82M	29.11M	24.95M	19.75M	57.1M
Other Income/Expense	-28.72M	-30.32M	-147.58M	-59.17M	-153.12M	-52.82M	-58.98M	69.11M	-1.42M	-47.2M
Pretax Income+	236.9M	208M	-11.99M	182.8M	50.49M	-119.01M	-121.78M	-2.07M	-67.13M	-822.92M
Pretax Margin %	0.06%	0.06%	-0%	0.05%	0.02%	-0.11%	-0.09%	-0%	-0.04%	-0.39%
Income Tax+	49.72M	62.81M	42.55M	-21K	31.63M	-44.58M	-19.53M	36.12M	-13.29M	4.49M
Effective Tax Rate %	0.71%	0.62%	-12.61%	0.77%	-10.45%	-0.36%	-0.59%	6.42%	0.5%	1%
Net Income+	167.74M	128.11M	151.09M	140.2M	-527.65M	42.63M	71.66M	-13.29M	-33.26M	-825.49M
Net Margin %	0.04%	0.04%	0.05%	0.04%	-0.16%	0.04%	0.05%	-0.01%	-0.02%	-0.39%
Net Income Growth %	-0.57%	-0.24%	0.18%	-0.07%	-4.76%	1.08%	0.68%	-1.19%	-1.5%	-23.82%
Net Income (Continuing)	176.95M	154.75M	46.08M	121.87M	18.86M	-74.43M	-102.25M	-38.19M	-53.84M	-827.42M
Discontinued Operations	10.23M	0	123.43M	32.6M	-536.01M	120.2M	178.53M	26.43M	21.11M	2.6M
Minority Interest	186.58M	196.47M	226.85M	207.19M	48.2M	44.49M	44.05M	1.72M	2.31M	2.07M
EPS (Diluted)+	4.02	3.12	3.66	3.48	0.41	1.11	-2.02	-0.28	-0.61	-14.93
EPS Growth %	-0.56%	-0.22%	0.17%	-0.05%	-0.88%	1.71%	-2.82%	0.86%	-1.18%	-23.48%
EPS (Basic)	4.05	3.12	3.69	3.50	0.42	1.13	-2.02	-0.28	-0.61	-14.93
Diluted Shares Outstanding	41.62M	41.07M	41.33M	40.29M	45.56M	46.3M	51.14M	54.07M	54.49M	55.28M
Basic Shares Outstanding	41.42M	41.06M	40.95M	40.1M	45.24M	45.59M	51.14M	54.07M	54.53M	55.28M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.76B	1.79B	2.07B	1.96B	1.4B	1.36B	2.3B	795.02M	896.52M	1.15B
Cash & Short-Term Investments	197.47M	221.73M	411.63M	245.02M	109.63M	101.07M	680.25M	24.3M	36.19M	48.17M
Cash Only	197.47M	221.73M	262.02M	245.02M	109.63M	101.07M	680.25M	24.3M	36.19M	48.17M
Short-Term Investments	0	0	149.61M	0	0	0	0	0	0	0
Accounts Receivable	888.17M	838.8M	970.2M	386.59M	561.87M	517.01M	254.96M	267.38M	291.48M	407.03M
Days Sales Outstanding	81.72	83.95	107.3	38.48	61.63	168.38	65.25	62.44	62.32	70.49
Inventory	420.39M	403.86M	429.63M	496.54M	571.56M	564.82M	356.23M	426.64M	468.83M	547.12M
Days Inventory Outstanding	56.51	58.93	69.06	71.52	108.29	398.72	200.5	224.48	238.86	215.46
Other Current Assets	253.74M	326M	258.38M	1.14B	90.76M	113.42M	985.79M	48.16M	71.11M	107.88M
Total Non-Current Assets+	4.97B	4.6B	4.65B	4.65B	5.98B	5.99B	6.21B	3.48B	3.61B	3.57B
Property, Plant & Equipment	644.54M	604.21M	552.8M	503.34M	664.56M	660.9M	311.6M	303.62M	334.3M	473.42M
Fixed Asset Turnover	6.15x	6.04x	5.97x	7.28x	5.01x	1.70x	4.58x	5.15x	5.11x	4.45x
Goodwill	2.82B	2.56B	2.54B	2.58B	3.2B	3.31B	1.93B	1.98B	2.06B	1.69B
Intangible Assets	995.71M	899.34M	1.02B	1.01B	1.72B	1.66B	1.15B	1.11B	1.13B	1.32B
Long-Term Investments	96.01M	92.27M	73.49M	62.52M	41.63M	31.82M	15.42M	16.5M	0	20.4M
Other Non-Current Assets	515.22M	532.98M	543.27M	552.56M	396.49M	350.83M	2.8B	80.29M	90.25M	68.38M
Total Assets+	6.73B	6.39B	6.72B	6.6B	7.39B	7.35B	8.52B	4.27B	4.51B	4.72B
Asset Turnover	0.59x	0.57x	0.49x	0.56x	0.45x	0.15x	0.17x	0.37x	0.38x	0.45x
Asset Growth %	-0.07%	-0.05%	0.05%	-0.02%	0.12%	-0%	0.16%	-0.5%	0.06%	0.05%
Total Current Liabilities+	1.12B	1.11B	1.1B	1.2B	857.31M	811.66M	1.02B	565.2M	369.61M	529M
Accounts Payable	569.45M	515.52M	587.13M	291.23M	359.78M	330.25M	155.21M	135.63M	132.47M	179.1M
Days Payables Outstanding	76.55	75.22	94.38	41.95	68.17	233.13	87.36	71.36	67.49	70.53
Short-Term Debt	5.79M	5.41M	5.77M	5.02M	67.66M	66.77M	29.64M	243.56M	21.57M	20.03M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	194.85M	276.04M	206.56M	758.5M	258.31M	222.16M	736.57M	101.72M	114.21M	188.97M
Current Ratio	1.58x	1.61x	1.89x	1.63x	1.64x	1.68x	2.25x	1.41x	2.43x	2.17x
Quick Ratio	1.20x	1.25x	1.49x	1.22x	0.97x	0.98x	1.90x	0.65x	1.16x	1.13x
Cash Conversion Cycle	61.68	67.65	81.99	68.05	101.76	333.97	178.39	215.55	233.69	215.42
Total Non-Current Liabilities+	2.36B	2.19B	1.9B	1.93B	3.04B	2.95B	2.83B	258.25M	719.03M	1.63B
Long-Term Debt	1.41B	1.29B	1.06B	1.19B	2.28B	2.2B	2.08B	40M	466.16M	1.31B
Capital Lease Obligations	0	0	0	0	136.4M	139.23M	56.55M	51.26M	48.68M	52.46M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	948.26M	898.7M	829.75M	747.26M	619.31M	608.62M	695.72M	166.99M	204.18M	263.52M
Total Liabilities	3.48B	3.29B	2.99B	3.13B	3.9B	3.76B	3.85B	823.45M	1.09B	2.15B
Total Debt+	1.42B	1.29B	1.06B	1.2B	2.49B	2.41B	2.16B	334.82M	536.42M	1.4B
Net Debt	1.22B	1.08B	799.05M	1.12B	2.38B	2.31B	1.48B	310.52M	500.23M	1.36B
Debt / Equity	0.44x	0.42x	0.28x	0.34x	0.71x	0.67x	0.46x	0.10x	0.16x	0.55x
Debt / EBITDA	3.23x	3.71x	6.95x	3.16x	5.66x	13.39x	10.82x	2.25x	3.54x	-
Net Debt / EBITDA	2.78x	3.11x	5.24x	2.96x	5.41x	12.82x	7.42x	2.09x	3.30x	-
Interest Coverage	5.96x	7.93x	0.73x	4.83x	1.70x	-1.25x	-2.16x	-2.85x	-3.33x	-13.59x
Total Equity+	3.26B	3.09B	3.73B	3.48B	3.49B	3.59B	4.66B	3.45B	3.42B	2.56B
Equity Growth %	-0.03%	-0.05%	0.2%	-0.07%	0%	0.03%	0.3%	-0.26%	-0.01%	-0.25%
Book Value per Share	78.24	75.33	90.18	86.31	76.60	77.49	91.15	63.81	62.77	46.39
Total Shareholders' Equity	3.07B	2.9B	3.5B	3.27B	3.44B	3.54B	4.62B	3.45B	3.42B	2.56B
Common Stock	123K	123K	123K	117K	118K	118K	52K	54K	55K	56K
Retained Earnings	557.3M	685.41M	846.49M	991.84M	479.56M	517.37M	589.02M	575.73M	542.47M	-283.02M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-686.72M	-988.35M	-574.37M	-780.18M	-483.85M	-452.11M	-516.01M	-53.43M	-24.88M	-127.89M
Minority Interest	186.58M	196.47M	226.85M	207.19M	48.2M	44.49M	44.05M	1.72M	2.31M	2.07M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	303.81M	246.97M	218.77M	226.37M	130.95M	301.94M	356.1M	-55.86M	134.99M	113.5M
Operating CF Margin %	0.08%	0.07%	0.07%	0.06%	0.04%	0.27%	0.25%	-0.04%	0.08%	0.05%
Operating CF Growth %	-0.21%	-0.19%	-0.11%	0.03%	-0.42%	1.31%	0.18%	-1.16%	3.42%	-0.16%
Net Income	187.18M	145.19M	169.51M	154.47M	-517.15M	45.77M	76.28M	-11.76M	-33.26M	-824.82M
Depreciation & Amortization	154.54M	143.26M	134.75M	141.88M	236.03M	246.23M	262.92M	219.71M	217.1M	284.8M
Stock-Based Compensation	16.32M	19.02M	21.55M	25.1M	21.96M	28.91M	35.35M	38.95M	34.06M	29.66M
Deferred Taxes	-22.72M	-1.68M	12.07M	-66.57M	-590K	-29.22M	-22.19M	6.32M	-27.41M	-10.02M
Other Non-Cash Items	10.1M	4.18M	-86.98M	4.82M	522.15M	5.25M	20.84M	-88.59M	-28.24M	647.81M
Working Capital Changes	-41.61M	-62.99M	-32.13M	-33.33M	-131.46M	4.99M	-17.1M	-220.49M	-27.27M	-13.93M
Change in Receivables	64.05M	-50.96M	-44.34M	-72.41M	49.92M	42.69M	-110.98M	-45.19M	-16.32M	-57.05M
Change in Inventory	-390K	19.66M	-34.02M	-47.16M	-44.89M	23.79M	-129.97M	-118.79M	-24.74M	39.07M
Change in Payables	-11.18M	52.31M	10.27M	70.08M	-119.33M	-30.75M	178.47M	-11.84M	-6.64M	13.98M
Cash from Investing+	-246.96M	-81.99M	89.88M	-167.85M	-1.63B	-175.08M	-320.48M	-176.39M	-242.47M	-955.47M
Capital Expenditures	-69.88M	-63.25M	-68.77M	-69.65M	-125.4M	-114.78M	-104.24M	-105.45M	-122.22M	-180.71M
CapEx % of Revenue	0.02%	0.02%	0.02%	0.02%	0.04%	0.1%	0.07%	0.07%	0.07%	0.09%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	18.93M	7.25M	15.1M	34.83M	7.78M	9.55M	7.03M	2.75M	32.57M	-4.84M
Cash from Financing+	-131.27M	-145.22M	-280.45M	-47.15M	1.37B	-131.65M	584.91M	-465.13M	127.8M	846.82M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-15.01M	-5.62M	-10.01M	-5.39M	248.83M	-16.84M	-9.87M	1.12B	-91.17M	-9.51M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	233.94M	183.72M	150M	156.72M	5.55M	187.15M	251.86M	-161.31M	12.77M	-67.21M
FCF Margin %	0.06%	0.05%	0.05%	0.04%	0%	0.17%	0.18%	-0.1%	0.01%	-0.03%
FCF Growth %	-0.23%	-0.21%	-0.18%	0.04%	-0.96%	32.75%	0.35%	-1.64%	1.08%	-6.27%
FCF per Share	5.62	4.47	3.63	3.89	0.12	4.04	4.92	-2.98	0.23	-1.22
FCF Conversion (FCF/Net Income)	1.81x	1.93x	1.45x	1.61x	-0.25x	7.08x	4.97x	4.20x	-4.06x	-0.14x
Interest Paid	36.36M	35.84M	43.5M	50.39M	139.27M	104.62M	85.49M	37.09M	16.33M	51.83M
Taxes Paid	79.54M	77.1M	70.67M	97.45M	134.91M	59.38M	47.19M	31.36M	12.52M	10.8M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	5.08%	4.04%	4.43%	3.89%	-15.15%	1.2%	1.74%	-0.33%	-0.97%	-27.59%
Return on Invested Capital (ROIC)	4.71%	4.13%	0.5%	3.97%	2.97%	-0.84%	-0.78%	-1.08%	-1.28%	-14.84%
Gross Margin	31.55%	31.41%	31.19%	30.89%	42.11%	53.86%	54.53%	55.62%	58.04%	56.02%
Net Margin	4.23%	3.51%	4.58%	3.82%	-15.86%	3.8%	5.02%	-0.85%	-1.95%	-39.17%
Debt / Equity	0.44x	0.42x	0.28x	0.34x	0.71x	0.67x	0.46x	0.10x	0.16x	0.55x
Interest Coverage	5.96x	7.93x	0.73x	4.83x	1.70x	-1.25x	-2.16x	-2.85x	-3.33x	-13.59x
FCF Conversion	1.81x	1.93x	1.45x	1.61x	-0.25x	7.08x	4.97x	4.20x	-4.06x	-0.14x
Revenue Growth	-14.22%	-8.07%	-9.51%	11.11%	-9.25%	-66.32%	27.26%	9.6%	9.22%	23.46%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Fabrication Technology	-	-	1.94B	260K	2.25B	1.95B	2.43B	-	-	-
Fabrication Technology Growth	-	-	-	-99.99%	864140.77%	-13.22%	24.51%	-	-	-
Medical Technology	-	-	-	-	1.08B	1.12B	1.43B	-	-	-
Medical Technology Growth	-	-	-	-	-	3.73%	27.26%	-	-	-
Air and Gas	-	-	1.36B	877.63M	-	-	-	-	-	-
Air and Gas Growth	-	-	-	-35.61%	-	-	-	-	-	-
Welding and Cutting	1.99B	1.8B	-	-	-	-	-	-	-	-
Welding and Cutting Growth	-	-9.31%	-	-	-	-	-	-	-	-
Gas Handling	1.45B	1.39B	-	-	-	-	-	-	-	-
Gas Handling Growth	-	-4.41%	-	-	-	-	-	-	-	-
Fluid Handling	532.7M	461.29M	-	-	-	-	-	-	-	-
Fluid Handling Growth	-	-13.40%	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	1.12B	995.19M	782.2M	877.95M	1.46B	1.28B	1.56B	1.06B	1.15B	1.25B
UNITED STATES Growth	-	-11.53%	-21.40%	12.24%	66.77%	-12.33%	21.84%	-32.05%	8.43%	8.10%
Foreign	2.84B	2.65B	2.52B	2.79B	1.86B	1.79B	2.29B	500.34M	554.84M	861.95M
Foreign Growth	-	-6.70%	-5.05%	10.76%	-33.19%	-4.09%	28.16%	-78.15%	10.89%	55.35%

Frequently Asked Questions

Growth & Financials

Enovis Corporation (ENOV) reported $2.23B in revenue for fiscal year 2024. This represents a 222% increase from $693.4M in 2011.

Enovis Corporation (ENOV) grew revenue by 23.5% over the past year. This is strong growth.

Enovis Corporation (ENOV) reported a net loss of $1.37B for fiscal year 2024.

Dividend & Returns

Enovis Corporation (ENOV) has a return on equity (ROE) of -27.6%. Negative ROE indicates the company is unprofitable.

Enovis Corporation (ENOV) generated $22.8M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Enovis Corporation (ENOV) 10-Year Financial Performance & Capital Metrics

ENOV • • Industrial / General

IndustrialsIndustrial MachinerySpecialized Industrial ComponentsFiltration & Sealing Systems

Revenue $2.11B +23.5%
EBITDA -$491M -424.3%
Net Income -$825M -2381.9%
EPS (Diluted) -14.93 -2347.5%
Gross Margin 56.02% -3.5%
EBITDA Margin -23.29% -362.7%
Operating Margin -36.81% -856.3%
Net Margin -39.17% -1910.3%
ROE -27.59% -2749.1%
ROIC -14.84% -1056.4%
Debt/Equity 0.55 +249.2%
Interest Coverage -13.59 -308.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.5x book value

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Weak momentum: RS Rating 17 (bottom 17%)
✗Sales declining 8.7% over 5 years
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-7.56%

5Y-8.73%

3Y13.9%

TTM11.57%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-1047.04%

EPS CAGR

10Y-

5Y-

3Y-

TTM-528.76%

ROCE

10Y Avg-0.59%

5Y Avg-4.7%

3Y Avg-7.19%

Latest-18.63%

Peer Comparison

Filtration & Sealing Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NPOEnPro Industries, Inc.	5.09B	241.74	70.07	-1%	7.81%	5.68%	2.55%	0.49
CSWCSW Industrials, Inc.	5.49B	328.94	39.25	10.78%	14.88%	12.5%	2.77%	0.06
DCIDonaldson Company, Inc.	11.62B	100.73	33.03	2.92%	10.25%	25.18%	2.93%	0.50
GTESGates Industrial Corporation plc	5.95B	23.05	31.15	-4.54%	6.93%	6.37%	4.98%	0.74
ITTITT Inc.	15.75B	183.08	29.06	10.59%	12.67%	18.09%	2.78%	0.27
ITWIllinois Tool Works Inc.	75.97B	261.89	22.36	-1.3%	19.05%	94.27%	3.74%	2.44
ENOVEnovis Corporation	1.39B	24.26	-1.62	23.46%	-61.22%	-67.56%		0.55

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	3.97B	3.65B	3.3B	3.67B	3.33B	1.12B	1.43B	1.56B	1.71B	2.11B
Revenue Growth %	-0.14%	-0.08%	-0.1%	0.11%	-0.09%	-0.66%	0.27%	0.1%	0.09%	0.23%
Cost of Goods Sold+	2.72B	2.5B	2.27B	2.53B	1.93B	517.06M	648.51M	693.72M	716.42M	926.87M
COGS % of Revenue	0.68%	0.69%	0.69%	0.69%	0.58%	0.46%	0.45%	0.44%	0.42%	0.44%
Gross Profit+	1.25B	1.15B	1.03B	1.13B	1.4B	603.64M	777.67M	869.38M	990.78M	1.18B
Gross Margin %	0.32%	0.31%	0.31%	0.31%	0.42%	0.54%	0.55%	0.56%	0.58%	0.56%
Gross Profit Growth %	-0.15%	-0.08%	-0.1%	0.1%	0.24%	-0.57%	0.29%	0.12%	0.14%	0.19%
Operating Expenses+	905.95M	825.24M	732.34M	818.21M	1.2B	669.82M	840.47M	940.56M	1.06B	1.96B
OpEx % of Revenue	0.23%	0.23%	0.22%	0.22%	0.36%	0.6%	0.59%	0.6%	0.62%	0.93%
Selling, General & Admin	905.95M	825.24M	732.34M	818.21M	1.13B	515.47M	665.77M	772.91M	830.3M	939.36M
SG&A % of Revenue	0.23%	0.23%	0.22%	0.22%	0.34%	0.46%	0.47%	0.49%	0.49%	0.45%
Research & Development	41.5M	39.3M	42.9M	34.2M	0	34.27M	49.09M	60.83M	75.33M	91.3M
R&D % of Revenue	0.01%	0.01%	0.01%	0.01%	-	0.03%	0.03%	0.04%	0.04%	0.04%
Other Operating Expenses	-21.09M	-8.23M	-46.93M	39K	65.3M	120.09M	125.61M	106.82M	150.85M	925.81M
Operating Income+	284.64M	238.01M	29.15M	236.94M	203.61M	-66.18M	-62.8M	-71.18M	-65.71M	-775.72M
Operating Margin %	0.07%	0.07%	0.01%	0.06%	0.06%	-0.06%	-0.04%	-0.05%	-0.04%	-0.37%
Operating Income Growth %	-0.3%	-0.16%	-0.88%	7.13%	-0.14%	-1.33%	0.05%	-0.13%	0.08%	-10.81%
EBITDA+	439.19M	347.88M	152.57M	378.82M	439.64M	180.05M	200.12M	148.53M	151.4M	-490.92M
EBITDA Margin %	0.11%	0.1%	0.05%	0.1%	0.13%	0.16%	0.14%	0.1%	0.09%	-0.23%
EBITDA Growth %	-0.25%	-0.21%	-0.56%	1.48%	0.16%	-0.59%	0.11%	-0.26%	0.02%	-4.24%
D&A (Non-Cash Add-back)	154.54M	109.86M	123.42M	141.88M	236.03M	246.23M	262.92M	219.71M	217.11M	284.8M
EBIT	276.05M	239.4M	36.99M	141.45M	170M	-66.18M	-92.67M	21.98M	-47.38M	-765.82M
Net Interest Income+	-47.5M	-30.28M	-40.11M	-49.08M	-119.5M	-52.82M	-29.11M	-24.75M	-19.75M	-57.1M
Interest Income	0	0	0	0	0	0	0	200K	0	0
Interest Expense	47.74M	30.02M	40.11M	49.08M	119.5M	52.82M	29.11M	24.95M	19.75M	57.1M
Other Income/Expense	-28.72M	-30.32M	-147.58M	-59.17M	-153.12M	-52.82M	-58.98M	69.11M	-1.42M	-47.2M
Pretax Income+	236.9M	208M	-11.99M	182.8M	50.49M	-119.01M	-121.78M	-2.07M	-67.13M	-822.92M
Pretax Margin %	0.06%	0.06%	-0%	0.05%	0.02%	-0.11%	-0.09%	-0%	-0.04%	-0.39%
Income Tax+	49.72M	62.81M	42.55M	-21K	31.63M	-44.58M	-19.53M	36.12M	-13.29M	4.49M
Effective Tax Rate %	0.71%	0.62%	-12.61%	0.77%	-10.45%	-0.36%	-0.59%	6.42%	0.5%	1%
Net Income+	167.74M	128.11M	151.09M	140.2M	-527.65M	42.63M	71.66M	-13.29M	-33.26M	-825.49M
Net Margin %	0.04%	0.04%	0.05%	0.04%	-0.16%	0.04%	0.05%	-0.01%	-0.02%	-0.39%
Net Income Growth %	-0.57%	-0.24%	0.18%	-0.07%	-4.76%	1.08%	0.68%	-1.19%	-1.5%	-23.82%
Net Income (Continuing)	176.95M	154.75M	46.08M	121.87M	18.86M	-74.43M	-102.25M	-38.19M	-53.84M	-827.42M
Discontinued Operations	10.23M	0	123.43M	32.6M	-536.01M	120.2M	178.53M	26.43M	21.11M	2.6M
Minority Interest	186.58M	196.47M	226.85M	207.19M	48.2M	44.49M	44.05M	1.72M	2.31M	2.07M
EPS (Diluted)+	4.02	3.12	3.66	3.48	0.41	1.11	-2.02	-0.28	-0.61	-14.93
EPS Growth %	-0.56%	-0.22%	0.17%	-0.05%	-0.88%	1.71%	-2.82%	0.86%	-1.18%	-23.48%
EPS (Basic)	4.05	3.12	3.69	3.50	0.42	1.13	-2.02	-0.28	-0.61	-14.93
Diluted Shares Outstanding	41.62M	41.07M	41.33M	40.29M	45.56M	46.3M	51.14M	54.07M	54.49M	55.28M
Basic Shares Outstanding	41.42M	41.06M	40.95M	40.1M	45.24M	45.59M	51.14M	54.07M	54.53M	55.28M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.76B	1.79B	2.07B	1.96B	1.4B	1.36B	2.3B	795.02M	896.52M	1.15B
Cash & Short-Term Investments	197.47M	221.73M	411.63M	245.02M	109.63M	101.07M	680.25M	24.3M	36.19M	48.17M
Cash Only	197.47M	221.73M	262.02M	245.02M	109.63M	101.07M	680.25M	24.3M	36.19M	48.17M
Short-Term Investments	0	0	149.61M	0	0	0	0	0	0	0
Accounts Receivable	888.17M	838.8M	970.2M	386.59M	561.87M	517.01M	254.96M	267.38M	291.48M	407.03M
Days Sales Outstanding	81.72	83.95	107.3	38.48	61.63	168.38	65.25	62.44	62.32	70.49
Inventory	420.39M	403.86M	429.63M	496.54M	571.56M	564.82M	356.23M	426.64M	468.83M	547.12M
Days Inventory Outstanding	56.51	58.93	69.06	71.52	108.29	398.72	200.5	224.48	238.86	215.46
Other Current Assets	253.74M	326M	258.38M	1.14B	90.76M	113.42M	985.79M	48.16M	71.11M	107.88M
Total Non-Current Assets+	4.97B	4.6B	4.65B	4.65B	5.98B	5.99B	6.21B	3.48B	3.61B	3.57B
Property, Plant & Equipment	644.54M	604.21M	552.8M	503.34M	664.56M	660.9M	311.6M	303.62M	334.3M	473.42M
Fixed Asset Turnover	6.15x	6.04x	5.97x	7.28x	5.01x	1.70x	4.58x	5.15x	5.11x	4.45x
Goodwill	2.82B	2.56B	2.54B	2.58B	3.2B	3.31B	1.93B	1.98B	2.06B	1.69B
Intangible Assets	995.71M	899.34M	1.02B	1.01B	1.72B	1.66B	1.15B	1.11B	1.13B	1.32B
Long-Term Investments	96.01M	92.27M	73.49M	62.52M	41.63M	31.82M	15.42M	16.5M	0	20.4M
Other Non-Current Assets	515.22M	532.98M	543.27M	552.56M	396.49M	350.83M	2.8B	80.29M	90.25M	68.38M
Total Assets+	6.73B	6.39B	6.72B	6.6B	7.39B	7.35B	8.52B	4.27B	4.51B	4.72B
Asset Turnover	0.59x	0.57x	0.49x	0.56x	0.45x	0.15x	0.17x	0.37x	0.38x	0.45x
Asset Growth %	-0.07%	-0.05%	0.05%	-0.02%	0.12%	-0%	0.16%	-0.5%	0.06%	0.05%
Total Current Liabilities+	1.12B	1.11B	1.1B	1.2B	857.31M	811.66M	1.02B	565.2M	369.61M	529M
Accounts Payable	569.45M	515.52M	587.13M	291.23M	359.78M	330.25M	155.21M	135.63M	132.47M	179.1M
Days Payables Outstanding	76.55	75.22	94.38	41.95	68.17	233.13	87.36	71.36	67.49	70.53
Short-Term Debt	5.79M	5.41M	5.77M	5.02M	67.66M	66.77M	29.64M	243.56M	21.57M	20.03M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	194.85M	276.04M	206.56M	758.5M	258.31M	222.16M	736.57M	101.72M	114.21M	188.97M
Current Ratio	1.58x	1.61x	1.89x	1.63x	1.64x	1.68x	2.25x	1.41x	2.43x	2.17x
Quick Ratio	1.20x	1.25x	1.49x	1.22x	0.97x	0.98x	1.90x	0.65x	1.16x	1.13x
Cash Conversion Cycle	61.68	67.65	81.99	68.05	101.76	333.97	178.39	215.55	233.69	215.42
Total Non-Current Liabilities+	2.36B	2.19B	1.9B	1.93B	3.04B	2.95B	2.83B	258.25M	719.03M	1.63B
Long-Term Debt	1.41B	1.29B	1.06B	1.19B	2.28B	2.2B	2.08B	40M	466.16M	1.31B
Capital Lease Obligations	0	0	0	0	136.4M	139.23M	56.55M	51.26M	48.68M	52.46M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	948.26M	898.7M	829.75M	747.26M	619.31M	608.62M	695.72M	166.99M	204.18M	263.52M
Total Liabilities	3.48B	3.29B	2.99B	3.13B	3.9B	3.76B	3.85B	823.45M	1.09B	2.15B
Total Debt+	1.42B	1.29B	1.06B	1.2B	2.49B	2.41B	2.16B	334.82M	536.42M	1.4B
Net Debt	1.22B	1.08B	799.05M	1.12B	2.38B	2.31B	1.48B	310.52M	500.23M	1.36B
Debt / Equity	0.44x	0.42x	0.28x	0.34x	0.71x	0.67x	0.46x	0.10x	0.16x	0.55x
Debt / EBITDA	3.23x	3.71x	6.95x	3.16x	5.66x	13.39x	10.82x	2.25x	3.54x	-
Net Debt / EBITDA	2.78x	3.11x	5.24x	2.96x	5.41x	12.82x	7.42x	2.09x	3.30x	-
Interest Coverage	5.96x	7.93x	0.73x	4.83x	1.70x	-1.25x	-2.16x	-2.85x	-3.33x	-13.59x
Total Equity+	3.26B	3.09B	3.73B	3.48B	3.49B	3.59B	4.66B	3.45B	3.42B	2.56B
Equity Growth %	-0.03%	-0.05%	0.2%	-0.07%	0%	0.03%	0.3%	-0.26%	-0.01%	-0.25%
Book Value per Share	78.24	75.33	90.18	86.31	76.60	77.49	91.15	63.81	62.77	46.39
Total Shareholders' Equity	3.07B	2.9B	3.5B	3.27B	3.44B	3.54B	4.62B	3.45B	3.42B	2.56B
Common Stock	123K	123K	123K	117K	118K	118K	52K	54K	55K	56K
Retained Earnings	557.3M	685.41M	846.49M	991.84M	479.56M	517.37M	589.02M	575.73M	542.47M	-283.02M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-686.72M	-988.35M	-574.37M	-780.18M	-483.85M	-452.11M	-516.01M	-53.43M	-24.88M	-127.89M
Minority Interest	186.58M	196.47M	226.85M	207.19M	48.2M	44.49M	44.05M	1.72M	2.31M	2.07M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	303.81M	246.97M	218.77M	226.37M	130.95M	301.94M	356.1M	-55.86M	134.99M	113.5M
Operating CF Margin %	0.08%	0.07%	0.07%	0.06%	0.04%	0.27%	0.25%	-0.04%	0.08%	0.05%
Operating CF Growth %	-0.21%	-0.19%	-0.11%	0.03%	-0.42%	1.31%	0.18%	-1.16%	3.42%	-0.16%
Net Income	187.18M	145.19M	169.51M	154.47M	-517.15M	45.77M	76.28M	-11.76M	-33.26M	-824.82M
Depreciation & Amortization	154.54M	143.26M	134.75M	141.88M	236.03M	246.23M	262.92M	219.71M	217.1M	284.8M
Stock-Based Compensation	16.32M	19.02M	21.55M	25.1M	21.96M	28.91M	35.35M	38.95M	34.06M	29.66M
Deferred Taxes	-22.72M	-1.68M	12.07M	-66.57M	-590K	-29.22M	-22.19M	6.32M	-27.41M	-10.02M
Other Non-Cash Items	10.1M	4.18M	-86.98M	4.82M	522.15M	5.25M	20.84M	-88.59M	-28.24M	647.81M
Working Capital Changes	-41.61M	-62.99M	-32.13M	-33.33M	-131.46M	4.99M	-17.1M	-220.49M	-27.27M	-13.93M
Change in Receivables	64.05M	-50.96M	-44.34M	-72.41M	49.92M	42.69M	-110.98M	-45.19M	-16.32M	-57.05M
Change in Inventory	-390K	19.66M	-34.02M	-47.16M	-44.89M	23.79M	-129.97M	-118.79M	-24.74M	39.07M
Change in Payables	-11.18M	52.31M	10.27M	70.08M	-119.33M	-30.75M	178.47M	-11.84M	-6.64M	13.98M
Cash from Investing+	-246.96M	-81.99M	89.88M	-167.85M	-1.63B	-175.08M	-320.48M	-176.39M	-242.47M	-955.47M
Capital Expenditures	-69.88M	-63.25M	-68.77M	-69.65M	-125.4M	-114.78M	-104.24M	-105.45M	-122.22M	-180.71M
CapEx % of Revenue	0.02%	0.02%	0.02%	0.02%	0.04%	0.1%	0.07%	0.07%	0.07%	0.09%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	18.93M	7.25M	15.1M	34.83M	7.78M	9.55M	7.03M	2.75M	32.57M	-4.84M
Cash from Financing+	-131.27M	-145.22M	-280.45M	-47.15M	1.37B	-131.65M	584.91M	-465.13M	127.8M	846.82M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-15.01M	-5.62M	-10.01M	-5.39M	248.83M	-16.84M	-9.87M	1.12B	-91.17M	-9.51M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	233.94M	183.72M	150M	156.72M	5.55M	187.15M	251.86M	-161.31M	12.77M	-67.21M
FCF Margin %	0.06%	0.05%	0.05%	0.04%	0%	0.17%	0.18%	-0.1%	0.01%	-0.03%
FCF Growth %	-0.23%	-0.21%	-0.18%	0.04%	-0.96%	32.75%	0.35%	-1.64%	1.08%	-6.27%
FCF per Share	5.62	4.47	3.63	3.89	0.12	4.04	4.92	-2.98	0.23	-1.22
FCF Conversion (FCF/Net Income)	1.81x	1.93x	1.45x	1.61x	-0.25x	7.08x	4.97x	4.20x	-4.06x	-0.14x
Interest Paid	36.36M	35.84M	43.5M	50.39M	139.27M	104.62M	85.49M	37.09M	16.33M	51.83M
Taxes Paid	79.54M	77.1M	70.67M	97.45M	134.91M	59.38M	47.19M	31.36M	12.52M	10.8M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	5.08%	4.04%	4.43%	3.89%	-15.15%	1.2%	1.74%	-0.33%	-0.97%	-27.59%
Return on Invested Capital (ROIC)	4.71%	4.13%	0.5%	3.97%	2.97%	-0.84%	-0.78%	-1.08%	-1.28%	-14.84%
Gross Margin	31.55%	31.41%	31.19%	30.89%	42.11%	53.86%	54.53%	55.62%	58.04%	56.02%
Net Margin	4.23%	3.51%	4.58%	3.82%	-15.86%	3.8%	5.02%	-0.85%	-1.95%	-39.17%
Debt / Equity	0.44x	0.42x	0.28x	0.34x	0.71x	0.67x	0.46x	0.10x	0.16x	0.55x
Interest Coverage	5.96x	7.93x	0.73x	4.83x	1.70x	-1.25x	-2.16x	-2.85x	-3.33x	-13.59x
FCF Conversion	1.81x	1.93x	1.45x	1.61x	-0.25x	7.08x	4.97x	4.20x	-4.06x	-0.14x
Revenue Growth	-14.22%	-8.07%	-9.51%	11.11%	-9.25%	-66.32%	27.26%	9.6%	9.22%	23.46%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Fabrication Technology	-	-	1.94B	260K	2.25B	1.95B	2.43B	-	-	-
Fabrication Technology Growth	-	-	-	-99.99%	864140.77%	-13.22%	24.51%	-	-	-
Medical Technology	-	-	-	-	1.08B	1.12B	1.43B	-	-	-
Medical Technology Growth	-	-	-	-	-	3.73%	27.26%	-	-	-
Air and Gas	-	-	1.36B	877.63M	-	-	-	-	-	-
Air and Gas Growth	-	-	-	-35.61%	-	-	-	-	-	-
Welding and Cutting	1.99B	1.8B	-	-	-	-	-	-	-	-
Welding and Cutting Growth	-	-9.31%	-	-	-	-	-	-	-	-
Gas Handling	1.45B	1.39B	-	-	-	-	-	-	-	-
Gas Handling Growth	-	-4.41%	-	-	-	-	-	-	-	-
Fluid Handling	532.7M	461.29M	-	-	-	-	-	-	-	-
Fluid Handling Growth	-	-13.40%	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	1.12B	995.19M	782.2M	877.95M	1.46B	1.28B	1.56B	1.06B	1.15B	1.25B
UNITED STATES Growth	-	-11.53%	-21.40%	12.24%	66.77%	-12.33%	21.84%	-32.05%	8.43%	8.10%
Foreign	2.84B	2.65B	2.52B	2.79B	1.86B	1.79B	2.29B	500.34M	554.84M	861.95M
Foreign Growth	-	-6.70%	-5.05%	10.76%	-33.19%	-4.09%	28.16%	-78.15%	10.89%	55.35%

Frequently Asked Questions

Growth & Financials

Enovis Corporation (ENOV) reported $2.23B in revenue for fiscal year 2024. This represents a 222% increase from $693.4M in 2011.

Enovis Corporation (ENOV) grew revenue by 23.5% over the past year. This is strong growth.

Enovis Corporation (ENOV) reported a net loss of $1.37B for fiscal year 2024.

Dividend & Returns

Enovis Corporation (ENOV) has a return on equity (ROE) of -27.6%. Negative ROE indicates the company is unprofitable.

Enovis Corporation (ENOV) generated $22.8M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.